Bayesian posterior probabilities of these dosing behaviors were derived by integrating validated population PK models, individual patient demographics (e.g., age, weight, creatinine clearance), dosing ...
The final, formatted version of the article will be published soon. Objective: This real-world study evaluated the efficacy and safety of telitacicept, a dual BAFF/APRIL inhibitor, in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback